Variant report
| Variant | rs11060167 |
|---|---|
| Chromosome Location | chr12:122676013-122676014 |
| allele | A/C |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:14)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:14 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr12:122675699..122678152-chr12:122686921..122688838,2 | MCF-7 | breast: | |
| 2 | chr12:122491891..122492950-chr12:122675163..122676073,7 | K562 | blood: | |
| 3 | chr12:122675858..122677484-chr12:122679022..122682895,3 | K562 | blood: | |
| 4 | chr12:122674046..122677306-chr12:122708798..122710546,3 | K562 | blood: | |
| 5 | chr12:122492288..122492924-chr12:122675554..122676136,3 | MCF-7 | breast: | |
| 6 | chr12:122615252..122616214-chr12:122675084..122676097,6 | K562 | blood: | |
| 7 | chr12:122661637..122664175-chr12:122674648..122677417,2 | K562 | blood: | |
| 8 | chr12:122661637..122663499-chr12:122674584..122677417,2 | K562 | blood: | |
| 9 | chr12:122186484..122187293-chr12:122675389..122676074,2 | MCF-7 | breast: | |
| 10 | chr12:122615211..122616210-chr12:122675123..122676106,13 | MCF-7 | breast: | |
| 11 | chr12:122674327..122677306-chr12:122708798..122710323,2 | K562 | blood: | |
| 12 | chr12:122674983..122677095-chr12:122689266..122691695,2 | K562 | blood: | |
| 13 | chr12:122675984..122678121-chr12:122679124..122682005,2 | K562 | blood: | |
| 14 | chr12:122469175..122470175-chr12:122675088..122676086,5 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| ENSG00000184047 | Chromatin interaction |
| ENSG00000176383 | Chromatin interaction |
| rs_ID | r2[population] |
|---|---|
| rs10848035 | 0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
| rs11060333 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.94[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];1.00[AMR][1000 genomes];0.93[EUR][1000 genomes];0.97[ASN][1000 genomes] |
| rs12423987 | 0.86[CEU][hapmap] |
| rs12578739 | 0.87[EUR][1000 genomes] |
| rs12578815 | 0.95[CEU][hapmap];0.89[TSI][hapmap];0.88[EUR][1000 genomes] |
| rs12578863 | 0.88[EUR][1000 genomes] |
| rs12810587 | 0.87[CEU][hapmap];0.81[CHD][hapmap];0.80[GIH][hapmap];0.83[JPT][hapmap] |
| rs12814923 | 0.95[CEU][hapmap] |
| rs12816400 | 0.85[EUR][1000 genomes] |
| rs12816499 | 0.95[CEU][hapmap];0.85[YRI][hapmap];0.88[EUR][1000 genomes] |
| rs12820704 | 0.94[CEU][hapmap];0.87[EUR][1000 genomes] |
| rs12822121 | 0.86[CEU][hapmap] |
| rs12824385 | 0.81[EUR][1000 genomes] |
| rs12824701 | 0.86[CEU][hapmap] |
| rs12824925 | 0.95[CEU][hapmap] |
| rs12825149 | 0.95[CEU][hapmap] |
| rs12825279 | 0.95[CEU][hapmap];0.83[TSI][hapmap] |
| rs12826834 | 0.88[EUR][1000 genomes] |
| rs12827843 | 0.88[EUR][1000 genomes] |
| rs12831210 | 0.83[EUR][1000 genomes] |
| rs1512023 | 0.86[CEU][hapmap] |
| rs2068223 | 0.95[CEU][hapmap];0.89[TSI][hapmap];0.87[EUR][1000 genomes] |
| rs2271408 | 0.95[CEU][hapmap];0.85[EUR][1000 genomes] |
| rs2271409 | 0.95[CEU][hapmap] |
| rs35030971 | 0.81[EUR][1000 genomes] |
| rs3809116 | 0.95[CEU][hapmap];0.89[TSI][hapmap];0.87[EUR][1000 genomes] |
| rs4758649 | 0.95[CEU][hapmap];0.93[TSI][hapmap];0.81[EUR][1000 genomes] |
| rs4758677 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.88[JPT][hapmap];0.88[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
| rs7388 | 0.95[CEU][hapmap] |
| rs872451 | 0.91[CEU][hapmap] |
Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | nsv529868 | chr12:121956483-122944265 | Flanking Active TSS Enhancers Weak transcription Active TSS Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 173 gene(s) | inside rSNPs | diseases |
| 2 | nsv916686 | chr12:122240149-122714056 | Enhancers Strong transcription Weak transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Active TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 89 gene(s) | inside rSNPs | diseases |
| 3 | nsv527450 | chr12:122481290-122676531 | Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
| 4 | nsv1038827 | chr12:122627371-122687913 | Bivalent/Poised TSS Genic enhancers Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 10 gene(s) | inside rSNPs | diseases |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr12:122668400-122676400 | Weak transcription | Brain Anterior Caudate | brain |
| 2 | chr12:122668400-122678400 | Weak transcription | Fetal Intestine Small | intestine |
| 3 | chr12:122668400-122681600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
| 4 | chr12:122670000-122683600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
| 5 | chr12:122674800-122685000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |





